FindTrial
Sign In

Peripheral blood lymphocytes analysis detects CD72 and CD100 alteration in trauma patients

Peripheral blood lymphocytes analysis detects CD72 and CD100 alteration in trauma patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026367
Enrollment
Unknown
Registered
2019-10-04
Start date
2019-10-03
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Gold Standard:clinical outcomes
Index test:the&#32
expression&#32
level&#32
of&#32
CD72&#32
and&#32
CD100&#32
on&#32
peripheral&#32
blood&#32
lymphocytes&#32

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Injury Severity Score >= 16; 2. Aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: 1. Patients who died within 24 hours of injury; 2. Patients with malignant tumors or chronic diarrhea; 3. Patients receiving immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
CD72;CD100;SEN, SPE, ACC, AUC of ROC;—

Secondary

MeasureTime frame
FGL2;IL-33;—

Countries

China

Contacts

Public ContactZhanfei Li

Trauma Center, Tongji Hospital, Tongji Mdeicine College, Huazhong University of Science and Technology

lezhfei@163.com+86 13986297128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026